Vaccination against COVID-19 in Individuals with Mental Illness

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Efficacy and Safety".

Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 1222

Special Issue Editors


E-Mail Website
Guest Editor
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Interests: substance disorders; depression; dementia; mental illness

E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Vaccination is one of the most cost-effective ways of avoiding contracting coronavirus disease 2019 (COVID-19). However, several issues regarding vaccination against COVID-19 among the individuals with mental illness warrants study. For, example, the individuals with severe mental illness have a lower rate of COVID-19 vaccine uptake compared with the general population. Caregivers of children with neurodevelopmental disorders may worry about the effects of vaccines against COVID-19. The predictors of vaccine uptake and programs to enhance the motivation and behavior of vaccine uptake among these groups warrant further exploration. The possible interaction between COVID-19 vaccines and psychopharmacological treatment and psychological symptoms are also not clear. This issue is open to the submission of studies investigating vaccination against COVID-19 among the individuals with various mental illnesses. The studies on this issue can provide knowledge to diminish the unknown in the effects of vaccination against COVID-19 among the individuals with mental illness.

Dr. Peng-Wei Wang
Prof. Dr. Cheng-Fang Yen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine for COVID-19
  • mental illness
  • drug interaction
  • adverse effects of vaccines
  • psychopharmacological treatment

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 282 KiB  
Article
Predicting the Influences of Depression and Sexual Stigma on Motivation to Get Vaccinated against COVID-19 in Lesbian, Gay, and Bisexual Young Adults: A 4-Year Follow-Up Study
by Yen-Ju Lin, Yu-Ping Chang and Cheng-Fang Yen
Vaccines 2023, 11(9), 1430; https://0-doi-org.brum.beds.ac.uk/10.3390/vaccines11091430 - 28 Aug 2023
Viewed by 941
Abstract
Vaccination is a crucial preventive measure against COVID-19. However, limited research has focused on identifying the factors predicting motivation to get vaccinated against COVID-19 (MoVAC-19) among lesbian, gay, and bisexual (LGB) individuals. This study examined the predictive effects of depression and sexual stigma [...] Read more.
Vaccination is a crucial preventive measure against COVID-19. However, limited research has focused on identifying the factors predicting motivation to get vaccinated against COVID-19 (MoVAC-19) among lesbian, gay, and bisexual (LGB) individuals. This study examined the predictive effects of depression and sexual stigma (i.e., perceived sexual stigma from family members, perceived sexual orientation microaggression, and internalized sexual stigma) before the COVID-19 pandemic on MoVAC-19 among LGB individuals 4 years later during the COVID-19 pandemic in Taiwan. Baseline data related to depression and sexual stigma were collected in 2018 and 2019. Depression was assessed using the 20-item Mandarin Chinese version of the Center for Epidemiologic Studies Depression Scale. Perceived sexual stigma from family members was assessed using the Homosexuality-Related Stigma Scale. Internalized sexual stigma was assessed using the Measure of Internalized Sexual Stigma for Lesbians and Gay Men. Perceived sexual orientation microaggression was assessed using the Sexual Orientation Microaggression Inventory. Participant MoVAC-19 during the pandemic was assessed using the nine-item Motors of COVID-19 Vaccination Acceptance Scale. The associations of depression and sexual stigma at baseline with MoVAC-19 at follow-up were examined through multivariate linear regression analysis. Internalized sexual stigma was negatively associated with MoVAC-19, whereas perceived sexual orientation microaggression was positively associated with MoVAC-19. Depression and perceived sexual stigma from family members were not significantly associated with MoVAC-19. Although male sex and older age were positively associated with increased MoVAC-19, sex and age did not moderate the relationship between sexual stigma and motivation to get vaccinated. Among LGB individuals, sexual stigma experiences should be considered when developing intervention strategies aimed at enhancing MoVAC-19. Full article
(This article belongs to the Special Issue Vaccination against COVID-19 in Individuals with Mental Illness)
Back to TopTop